This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Non-Hodgkin lymphoma
  • /
  • Health-related quality of life and symptoms in pat...
Journal

Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone.

Read time: 1 mins
Published:1st Feb 2017
Author: Cheson BD, Trask PC, Gribben JG, Dimier N, Kimby E, Lugtenburg PJ, et al.
Availability: Free full text
Ref.:Ann Hematol. 2017 Feb;96(2):253-259.
DOI:10.1007/s00277-016-2878-5.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest